JUOSTMEDIS, UAB - financials and debts

Company age: 27 y. 8 mo.

Update

JUOSTMEDIS - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 577,235 638,223 618,097 559,032 414,758 499,986 575,696 421,746
Profit before tax -23,388 -38,268 16,592 7,997 5,502 5,545 6,531 10,208
Net profit -23,388 -38,268 14,103 5,873 4,677 4,713 5,551 8,575
Equity 272,146 233,879 247,982 253,855 256,496 261,209 266,760 275,335
Liabilities 184,117 140,710 120,373 127,590 151,219 131,306 142,749 126,664
Non-current assets 115,317 95,875 76,206 59,764 44,013 43,800 48,032 86,821
Current assets 363,546 295,791 303,703 327,712 365,619 348,715 361,477 315,178
Total assets 478,863 391,666 379,909 387,476 409,632 392,515 409,509 401,999
Taxes paid
Social insurance contributions - - - - - 30,987 32,708 31,771
Financial indicators
Revenue change y/y +12.6% +10.6% -3.2% -9.6% -25.8% +20.5% +15.1% -26.7%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -4.9% -9.8% 3.7% 1.5% 1.1% 1.2% 1.4% 2.1%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. -8.6% -16.4% 5.7% 2.3% 1.8% 1.8% 2.1% 3.1%
Profit margin Net profit margin. Shows the overall profitability of the company. -4.1% -6.0% 2.3% 1.1% 1.1% 0.9% 1.0% 2.0%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. -4.1% -6.0% 2.7% 1.4% 1.3% 1.1% 1.1% 2.4%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.7 0.6 0.5 0.5 0.6 0.5 0.5 0.5
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 39,809 50,386 45,504 37,688 32,319 39,999 52,336 43,256

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

JUOSTMEDIS - Social security debts

From To Debt, €
2026-07-19 2026-07-19 325.81
2026-07-16 2026-07-17 325.81
2026-04-27 2026-04-29 169.08
2026-04-26 2026-04-26 533.88
2026-04-23 2026-04-25 537.33
2026-04-20 2026-04-22 533.88
2026-03-27 2026-03-27 1938.56
2026-03-17 2026-03-18 1938.56
2026-02-12 2026-02-17 2.31
2026-01-16 2026-01-19 1123.50
2025-12-16 2025-12-16 1132.60
2025-11-18 2025-11-20 1130.20
2025-02-18 2025-02-20 11.81
2024-10-24 2024-11-12 3.05
2024-08-19 2024-08-19 2631.19
2024-05-16 2024-05-19 363.50
2023-10-17 2023-10-19 422.09
2023-06-16 2023-06-19 2316.11
2023-05-02 2023-05-03 2.11
2023-04-25 2023-04-28 2.11
2023-03-16 2023-03-19 20.80
2023-01-23 2023-01-24 1.06
2023-01-17 2023-01-18 61.68

JUOSTMEDIS - VMI tax arrears

From To Overdue, €
2026-01-22 2026-01-23 418.31
2026-01-20 2026-01-21 418.2
2026-01-18 2026-01-19 417.87
2026-01-17 2026-01-17 416.11
2026-01-16 2026-01-16 415.2
2025-06-24 2025-06-26 0.12
2025-06-20 2025-06-23 166.02
2025-06-19 2025-06-19 165.9
2025-01-15 2025-01-15 440.34
2024-10-03 2024-10-16 0.13

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
JUOSTMEDIS, UAB (code 183115519) is a Private Limited Liability Company engaged in the manufacture of other products of wood and articles of cork, straw and plaiting materials. In the latest financial year, 2025, the company generated revenue of EUR 421.7K and net profit of EUR 8.6K, with a profit margin of 2.0%. Revenue decreased by 26.7% year on year, and compared with 2023 revenue was also lower, indicating a weaker top-line trend over the last two years. At the same time, net profit improved from EUR 4.7K in 2023 to EUR 5.6K in 2024 and EUR 8.6K in 2025, showing better profitability despite lower sales. Total assets at the end of 2025 stood at EUR 402.0K, supported by equity of EUR 275.3K and liabilities of EUR 126.7K. The equity ratio was 68.5%, debt-to-equity 0.46, ROE 3.1%, ROA 2.1%, and asset turnover 1.05x. Revenue per employee was EUR 46.9K.